An additional point was treated in eight cases: the liver-biliary tract point (MA-SC7) in four cases; the stomach point (MA–SC8) in two cases in patients presenting with severe nausea during migraine attacks; the ACTH (MA-IT2) point once and the FSH-LH (MA-LO2) point once. The gene discussed is BRD2; the disease is migraine disorder.